Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Cash from Operations (2020 - 2025)

Intelligent Bio Solutions has reported Cash from Operations over the past 5 years, most recently at 2446564.0 for Q1 2024.

  • For Q1 2024, Cash from Operations rose 2.85% year-over-year to 2446564.0; the TTM value through Mar 2024 reached 7211893.0, up 15.32%, while the annual FY2023 figure was 7377378.0, 119.69% down from the prior year.
  • Cash from Operations for Q1 2024 was 2446564.0 at Intelligent Bio Solutions, up from 2869158.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 194975.0 in Q2 2020 and troughed at 6159435.0 in Q1 2021.
  • A 5-year average of 1687242.35 and a median of 1682811.0 in 2021 define the central range for Cash from Operations.
  • On a YoY basis, Cash from Operations climbed as much as 103.1% in 2021 and fell as far as 2717.02% in 2021.
  • Year by year, Cash from Operations stood at 776967.0 in 2020, then crashed by 83.48% to 1425567.0 in 2021, then crashed by 67.01% to 2380850.0 in 2022, then decreased by 20.51% to 2869158.0 in 2023, then grew by 14.73% to 2446564.0 in 2024.
  • Business Quant data shows Cash from Operations for INBS at 2446564.0 in Q1 2024, 2869158.0 in Q4 2023, and 1311833.0 in Q3 2023.